Shopping Cart
- Remove All
- Your shopping cart is currently empty
TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $148 | Backorder | |
2 mg | $267 | Backorder | |
5 mg | $592 | Backorder |
Description | TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors. |
In vitro | TAPI-1 prevents unstimulated and PMA-induced release of the soluble forms of TNF-alpha, p60 TNFR, and IL-6R from the monocytic cell line, THP-1, and from human peripheral blood monocytes. TAPI also inhibits LPS-induced shedding of the p60 TNFR and TNF-alpha from monocytes. TAPI-1 inhibits TACE-dependent constitutive release of co-transfected APP(695). TAPI-1 attenuates Ang II-induced EGFR transactivation and cell proliferation in human HSC line LI90. TAPI-1 with the EGFR inhibitor AG1478 exhibits deactivated AREG/EGFR/ERK signaling pathway and reduces pro-inflammatory cytokines release in pSS salivary gland-derived epithelial cells. |
Molecular Weight | 613.62 |
Formula | C28H38F3N5O7 |
Smiles | OC(=O)C(F)(F)F.CC(C)CC(CC(=O)NO)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)NCCN |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 10 mM | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.